Larimar Therapeutics, Inc. (LRMR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 277.93M |
| Enterprise Value | 196.59M |
| P/E Ratio | -1.77 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.87 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.8 |
| Return On Equity | -1.34 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -165.32M |
| Net Income | -165.67M |
| Diluted EPS | -2.27 |
Balance Sheet
| Total Cash | 200.39M |
| Total Cash/Share | 2.35 |
| Total Debt | 3.78M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 4.29 |
| Book Value Per Share | 1.86 |
Price History
| 52-Week Change | 53.8 |
| 52-Week High | 6.42 |
| 52-Week Low | 2.55 |
| Moving Average 50 Days | 3.91 |
| Moving Average 200 Days | 3.99 |
Statistics
| Average Volume | 1.73M |
| Shares Outstanding | 85.58M |
| % Held by Institutions | 120.3 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | May 29, 2020 |
AD
